Tech Company Financing Transactions
Nora Therapeutics Funding Round
Burrill & Company, Prospect Venture Partners and Vivo Capital invested in a $1.9 million funding round for Nora Therapeutics. The funding round was recorded on 6/30/2010.
Transaction Overview
Company Name
Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
$1,932,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
530 Lytton Ave. 2nd Floor
Palo Alto, CA 94301
USA
Palo Alto, CA 94301
USA
Phone
Website
Email Address
Overview
Nora Therapeutics is a specialty biopharmaceutical company focused on developing therapeutics to address clinical unmet needs in reproductive medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Tong
Chief Medical Officer
Paul Kwon
VP - Bus. Development
Chris McClain
VP - Marketing
Sandra Shpilberg
VP - Operations
Mark Joing
VP - Product Management
Vera Wolowodiuk
VP - R & D
Darryl Carter
Browse more venture capital transactions:
Prev: 6/30/2010: Flat World Education venture capital transaction
Next: 6/30/2010: SmartPill venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs